|1.||Vardhan, N R Harsha: 1 article (07/2015)|
|2.||Reddy, Ram Bhupal: 1 article (07/2015)|
|3.||Palve, Vinayak: 1 article (07/2015)|
|4.||Chandola, Udita: 1 article (07/2015)|
|5.||Jain, Prachi: 1 article (07/2015)|
|6.||Panda, Binay: 1 article (07/2015)|
|7.||Kuriakose, Moni Abraham: 1 article (07/2015)|
|8.||Nair, Jayalakshmi: 1 article (07/2015)|
|9.||Kekatpure, Vikram D: 1 article (07/2015)|
|10.||Suresh, Amritha: 1 article (07/2015)|
02/01/2013 - "Similar to recent findings on hsa-miR-375, ectopic expression of hsa-miR-203 in cervical cancer cells decreased both the proliferation rate and anchorage independent growth. "
07/01/2015 - "Alongside gene expression, the microRNAs hsa-miR-139, hsa-miR-203 and the hsa-miR-424/503 cluster have aberrant expression in these cancers. "
04/01/2014 - "Up-regulated hsa-miR-21 and down-regulated hsa-miR-203 were identified by comparing normal and cancer tissue samples, and the targets genes regulated by these two miRNAs were most significantly related to cell cycle function and pathway, especially in the phase of G1/S. "
04/01/2014 - "The two differentially expressed miRNA: hsa-miR-21 and hsa-miR-203 provide evidence for early diagnosis and treatment of esophageal carcinoma. "
02/01/2013 - "All three miRNAs showed significantly increased levels of methylation in cervical carcinomas, whereas methylation levels of hsa-miR-203 and -375 were also significantly increased in high-grade CIN. "
|3.||Stomach Neoplasms (Stomach Cancer)
|4.||Non-Hodgkin Lymphoma (Lymphosarcoma)
12/01/2011 - "We studied the methylation of hsa-miR-203 in 150 samples including acute myeloid leukaemia (AML), acute lymphoblastic leukaemia (ALL), chronic myeloid leukaemia (CML), chronic lymphocytic leukaemia (CLL) and non-Hodgkin's lymphoma (NHL) by methylation-specific PCR, and miRNA expression by stem-loop RT-qPCR. "